Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

Clinical trial NCT03023319 · COMPLETED

Trial details

NCT number: NCT03023319
Sponsor: Nagla Abdel Karim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Mesothelioma Bladder Cancer Ovarian Cancer Peritoneal Cancer Thymoma Thymus Cancer Uterine Cervical Cancer

Start date: 2019-12-10
Primary completion: 2022-05-10
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.